Whitehawk Therapeutics
About Whitehawk Therapeutics
Whitehawk Therapeutics develops investigational medicines and drug candidates. The portfolio centers on discovering, engineering, and progressing therapies for serious diseases, with focus on oncology and immune-driven conditions. Capabilities include target discovery, lead optimization, preclinical pharmacology, and early clinical evaluation supported by translational biomarkers. Offerings to partners include research collaborations, asset licensing, and co-development arrangements to move pipeline programs forward. Publicly available information indicates that programs remain in research and clinical trial stages and are not approved for commercial use.
Company Facts
- Legal name: Whitehawk Therapeutics, Inc.
- Operating status: Operating
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Estimated revenue: $1K – $10K
- Website: whitehawktx.com
- Phone: +1 551 321 2234
Social Profiles
Canonical: https://fsome.com/organization/whitehawk-therapeutics-8455196 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.